Evidence map›Paper›PMID 38753575›Full record

ArticlePLoS pathogens2024

Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery.

Aaron Embry, Nina S Baggett, David B Heisler, Addison White, Maarten F de Jong, Benjamin L Kocsis, Diana R Tomchick, Neal M Alto, Don B Gammon

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Bacterial and human exonucleases mediate interkingdom antiviral immunity.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Activation and Evasion of the FEAR Pathway by RNA Viruses.bioRxiv : the preprint server for biology · 2025
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Aaron EmbryDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Nina S BaggettDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
David B HeislerDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Addison WhiteDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Maarten F de JongDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Benjamin L KocsisDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Diana R TomchickDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Neal M AltoDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.
Don B GammonDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United State of America.ORCID 0000-0003-1144-4152

Funding

MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
$7.0M
Type III effector regulation of host signal transduction systemsR01AI083359 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ALTO, NEAL MATHEW · 2009 to 2024
$6.3M
Exploiting Pathogen-Encoded Immune Evasion Proteins to Uncover Evolutionarily Conserved Antiviral Host MachineryR35GM137978 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Don Brad Gammon · 2020 to 2026
$2.5M
Using Bacterial Effectors to Uncover Innate Immune Mechanisms Restricting Viral Replication in Bat CellsR21AI169558 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GAMMON, DON BRAD · 2023 to 2024
$451k
NIAID NIH HHS R01 AI083359NIAID NIH HHS R21 AI169558NIAID NIH HHS T32 AI007520NIGMS NIH HHS R35 GM137978
6 · The paper itself

Abstract

Arboviruses are a diverse group of insect-transmitted pathogens that pose global public health challenges. Identifying evolutionarily conserved host factors that combat arbovirus replication in disparate eukaryotic hosts is important as they may tip the balance between productive and abortive viral replication, and thus determine virus host range. Here, we exploit naturally abortive arbovirus infections that we identified in lepidopteran cells and use bacterial effector proteins to uncover host factors restricting arbovirus replication. Bacterial effectors are proteins secreted by pathogenic bacteria into eukaryotic hosts cells that can inhibit antimicrobial defenses. Since bacteria and viruses can encounter common host defenses, we hypothesized that some bacterial effectors may inhibit host factors that restrict arbovirus replication in lepidopteran cells. Thus, we used bacterial effectors as molecular tools to identify host factors that restrict four distinct arboviruses in lepidopteran cells. By screening 210 effectors encoded by seven different bacterial pathogens, we identify several effectors that individually rescue the replication of all four arboviruses. We show that these effectors encode diverse enzymatic activities that are required to break arbovirus restriction. We further characterize Shigella flexneri-encoded IpaH4 as an E3 ubiquitin ligase that directly ubiquitinates two evolutionarily conserved proteins, SHOC2 and PSMC1, promoting their degradation in insect and human cells. We show that depletion of either SHOC2 or PSMC1 in insect or human cells promotes arbovirus replication, indicating that these are ancient virus restriction factors conserved across invertebrate and vertebrate hosts. Collectively, our study reveals a novel pathogen-guided approach to identify conserved antimicrobial machinery, new effector functions, and conserved roles for SHOC2 and PSMC1 in virus restriction.

Indexed as

Bacterial ProteinsHost-Pathogen InteractionsVirus ReplicationAnimalsArbovirusesArbovirus InfectionsCell LineHumansShigella flexneriBacterial Proteins

Identifiers

PMID38753575
PMCPMC11098378

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.